Skip to main content

Day: August 24, 2022

Lerøy Seafood Group ASA: Q2 2022 Results

HIGH PRICES GIVES RECORD HIGH QUARTERLY REVENUE Operating profit for Q2 2022 excluding settlement costs and before fair value adjustment is NOK 923 million, up 58% on the same period of 2021. Strong demand for seafood, including a substantial increase in prices realised for the Group’s main products, is the key factor in the year-on-year earnings improvement. The Farming segment delivered improved results in the quarter. Salmon prices were high again in the second quarter, based on continued high demand and low supply. The harvest volume was slightly lower than in the same period of 2021 but will increase in the second half of the year. Inflationary pressure in the economy and the low harvest volume are affecting cost developments. The total salmon and trout harvest volume for full-year 2022 is estimated at 203,000 GWT (including Lerøy’s...

Continue reading

CORRECTION — Fanhua Reports Second Quarter and First Half 2022 Unaudited Financial Results

GUANGZHOU, China, Aug. 24, 2022 (GLOBE NEWSWIRE) — Fanhua Inc. (Nasdaq: FANH) (the “Company” or “Fanhua”), a leading independent financial services provider in China, today announced a correction of a prior press release, “Fanhua Reports Second Quarter and First Half 2022 Unaudited Financial Results” issued at 5PM on August 23, 2022. The cash, cash equivalents and restricted cash at beginning of period for the six months ended June 20, 2021 in the unaudited condensed consolidated statement of cash flow should read “350,098” instead of “1,219,436” and the cash, cash equivalents and restricted cash at end of period for the six months ended June 20, 2021 in the unaudited condensed consolidated statement of cash flow should read “429,330” instead of “1,298,668” as originally issued inadvertently. The complete, correct release follows. Fanhua...

Continue reading

Company Announcement 10/2022

August 24, 2022 NORDIC SHIPHOLDING A/SCompany Announcement: 10/2022 Published via NASDAQ OMX on August 24, 2022H1 Result 2022SummaryThe comparison figures for the period ended 30 June 2022 are stated in parenthesis.The operating performance of the Group for H1 2022 was impacted by the sale of the remaining three vessels. The last vessel, Nordic Amy, was delivered to her new owner on 1 April 2022. The Group generated a profit after tax of USD 3.6 million (including write-off of certain loan interest of USD 3.9 million on the vessels) in H1 2022 compared to a loss after tax of USD 6.0 million for the same period last year. TCE revenue in Q2 2022 was recognised due to IFRS 15 reversals and revision of previous periods’ pool distributions by pool managers. Despite the improvement in average TCE rates in Q1 2022, the loss of earnings...

Continue reading

Allied Copper provides Update on Stateline Option Agreement

Vancouver, British Columbia, Canada, Aug. 23, 2022 (GLOBE NEWSWIRE) — Allied Copper Corp. (TSX-V: CPR, OTCQB: CPRRF) (the “Company” or “Allied Copper”), previously announced on February 10, 2022 that the Company signed an option agreement (the “Agreement”) dated February 9, 2022 for the sole and exclusive right to acquire a 100% undivided legal and beneficial interest (subject to a 2% net smelter royalty) for the Stateline Property, CO/UT USA from Cloudbreak Discovery Plc (“Cloudbreak” (LSE: CDL), Cloudbreak Discovery Canada Ltd., Tarsis Resources US Inc. and Alianza Minerals Ltd. (“Alianza”) (TSX-V: ANZ) (collectively, the “Alliance”). The Company and the Alliance have now successfully executed an amending agreement dated August 5, 2022 with effect as of February 9, 2022, amending the Agreement to delay any security issuance by...

Continue reading

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (“Bright Minds” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain, is pleased to announce the pricing of its previously announced overnight marketed offering of an aggregate of 2,858,000 units of the Company (the “Units”) at a price of $1.40 per Unit, for aggregate gross proceeds of $4,001,200 (the “Offering”). Each Unit is comprised of one common share in the capital of the Company (a “Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Share at an exercise...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.